-
MS Specialist to Lead Trial of Temelimab in Progressing Disease Without Relapses
A clinical trial in Sweden will test temelimab, an antibody GeNeuro designed to help remyelination, in MS patients with disease progression and no relapses. Learn more about the trial here.
Are you interested in following this research as it progresses?
Sorry, there were no replies found.
Log in to reply.